Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial

Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    - Revision label updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T02:24:32.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page received a new site revision notice (Revision: v3.4.2) and an older notice (Revision: v3.4.1) was removed; these changes affect only site messaging and do not modify the study details, eligibility criteria, or data displayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:59.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a government-funding site status notice and updated the page version to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:27:58.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now includes a glossary feature and a plain-language trial summary link (novctrd.com), with the revision updated to v3.4.0 and the latest QC submission dated 2026-01-26. The older QC date (2023-04-24) and No FEAR Act data entries were removed.
    Difference
    0.4%
    Check dated 2026-01-28T06:23:00.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. The study details and page structure remain unchanged.
    Difference
    0.0%
    Check dated 2026-01-14T03:27:58.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Locations now list multiple states (California, Florida, Illinois, Maryland, Massachusetts, Missouri, Ohio, Pennsylvania, Texas, Utah) on the study page, and the revision tag shows v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:08:15.000Z thumbnail image

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.